139 related articles for article (PubMed ID: 7912253)
1. Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine.
Dharakul T; Kurane I; Bhamarapravati N; Yoksan S; Vaughn DW; Hoke CH; Ennis FA
J Infect Dis; 1994 Jul; 170(1):27-33. PubMed ID: 7912253
[TBL] [Abstract][Full Text] [Related]
2. Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination.
Green S; Kurane I; Edelman R; Tacket CO; Eckels KH; Vaughn DW; Hoke CH; Ennis FA
J Virol; 1993 Oct; 67(10):5962-7. PubMed ID: 8371350
[TBL] [Abstract][Full Text] [Related]
3. Human CD4
Angelo MA; Grifoni A; O'Rourke PH; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974563
[TBL] [Abstract][Full Text] [Related]
4. Serotype-specific T(H)1 responses in recipients of two doses of candidate live-attenuated dengue virus vaccines.
Gwinn W; Sun W; Innis BL; Caudill J; King AD
Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):39-47. PubMed ID: 14740954
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining.
Mangada MM; Ennis FA; Rothman AL
J Immunol Methods; 2004 Jan; 284(1-2):89-97. PubMed ID: 14736419
[TBL] [Abstract][Full Text] [Related]
6. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.
Mathew A; Kurane I; Rothman AL; Zeng LL; Brinton MA; Ennis FA
J Clin Invest; 1996 Oct; 98(7):1684-91. PubMed ID: 8833919
[TBL] [Abstract][Full Text] [Related]
7. Dengue virus-specific, human CD4+ cytotoxic T lymphocytes generated in short-term culture.
Zivny J; Kurane I; Tacket CO; Edelman R; Ennis FA
Viral Immunol; 1993; 6(2):143-51. PubMed ID: 8105794
[TBL] [Abstract][Full Text] [Related]
8. Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine.
Rothman AL; Kanesa-thasan N; West K; Janus J; Saluzzo JF; Ennis FA
Vaccine; 2001 Sep; 19(32):4694-9. PubMed ID: 11535318
[TBL] [Abstract][Full Text] [Related]
9. Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.
Gagnon SJ; Zeng W; Kurane I; Ennis FA
J Virol; 1996 Jan; 70(1):141-7. PubMed ID: 8523518
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.
Kanesa-thasan N; Sun W; Kim-Ahn G; Van Albert S; Putnak JR; King A; Raengsakulsrach B; Christ-Schmidt H; Gilson K; Zahradnik JM; Vaughn DW; Innis BL; Saluzzo JF; Hoke CH
Vaccine; 2001 Apr; 19(23-24):3179-88. PubMed ID: 11312014
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate.
Chu H; George SL; Stinchcomb DT; Osorio JE; Partidos CD
J Infect Dis; 2015 Nov; 212(10):1618-28. PubMed ID: 25943203
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain.
Grifoni A; Angelo M; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Botten J; Boyson J; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148797
[TBL] [Abstract][Full Text] [Related]
13. Dengue virus specific T cell responses to live attenuated monovalent dengue-2 and tetravalent dengue vaccines.
Rabablert J; Dharakul T; Yoksan S; Bhamarapravati N
Asian Pac J Allergy Immunol; 2000 Dec; 18(4):227-35. PubMed ID: 11316044
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.
Guy B; Nougarede N; Begue S; Sanchez V; Souag N; Carre M; Chambonneau L; Morrisson DN; Shaw D; Qiao M; Dumas R; Lang J; Forrat R
Vaccine; 2008 Oct; 26(45):5712-21. PubMed ID: 18762226
[TBL] [Abstract][Full Text] [Related]
15. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
16. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes.
Konishi E; Kurane I; Mason PW; Innis BL; Ennis FA
Am J Trop Med Hyg; 1995 Sep; 53(3):278-83. PubMed ID: 7573713
[TBL] [Abstract][Full Text] [Related]
17. Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones.
Green S; Kurane I; Pincus S; Paoletti E; Ennis FA
Virology; 1997 Aug; 234(2):383-6. PubMed ID: 9268170
[TBL] [Abstract][Full Text] [Related]
18. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity.
Weiskopf D; Bangs DJ; Sidney J; Kolla RV; De Silva AD; de Silva AM; Crotty S; Peters B; Sette A
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):E4256-63. PubMed ID: 26195744
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of susceptibility and transmissibility of the live, attenuated, candidate vaccines dengue-1 PDK13, dengue-3 PGMK30F3, and dengue-4 PDK48 after oral infection in Aedes aegypti.
Jirakanjanakit N; Khin MM; Yoksan S; Bhamarapravati N
Am J Trop Med Hyg; 1999 Oct; 61(4):672-6. PubMed ID: 10548309
[TBL] [Abstract][Full Text] [Related]
20. Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers.
Bhamarapravati N; Yoksan S; Chayaniyayothin T; Angsubphakorn S; Bunyaratvej A
Bull World Health Organ; 1987; 65(2):189-95. PubMed ID: 3496985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
